Antibe Therapeutics Inc (ATBPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATBPF | AMGN | GILD | VRTX | BIIB |
| Company | Antibe Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.2328 | 337.03 | 84.39 | 477.70 | 200.57 |
| High | 0.2452 | 338.70 | 84.65 | 482.00 | 204.18 |
| Low | 0.1889 | 334.61 | 83.57 | 476.27 | 200.11 |
| Last | 0.2156 | 336.26 | 84.36 | 479.05 | 201.67 |
| Change | +0.0256 | +3.34 | +0.47 | +4.89 | +4.08 |
| % Change | +13.47% | +1.00% | +0.56% | +1.03% | +2.06% |
| Volume | 33,900 | 477,698 | 2,491,044 | 255,630 | 370,876 |
| 20-Day Average Volume | 41,625 | 1,702,433 | 6,374,733 | 951,574 | 790,176 |
| Previous Close | 0.1900 | 332.92 | 83.89 | 474.16 | 197.59 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.2805 | 329.61 | 80.09 | 479.97 | 201.58 |
| 20-Day Raw Stochastic | 40.74% | 87.00% | 92.75% | 48.94% | 60.68% |
| 20-Day Relative Strength | 34.47% | 58.00% | 72.44% | 50.47% | 44.70% |
| Weighted Alpha | +1.76 | +27.33 | +18.82 | +34.37 | -21.83 |
| Today's Opinion | 56% Sell | 96% Buy | 88% Buy | 56% Buy | 100% Sell |
| Previous Opinion | 56% Sell | 88% Buy | 88% Buy | 40% Buy | 100% Sell |
| Last Month's Opinion | 8% Sell | 88% Buy | 56% Buy | 88% Buy | 88% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +86.99% since 04/01/24 | +1.92% since 09/12/24 | +1.25% since 09/12/24 | +0.29% since 09/12/24 | +1.60% since 09/12/24 |
| Low | 0.1113 on 04/02/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 473.75 on 09/18/24 | 192.25 on 09/13/24 |
| High | 0.2452 on 04/08/24 | 339.00 on 09/18/24 | 84.61 on 09/19/24 | 490.15 on 09/16/24 | 204.18 on 09/19/24 |
| 1-Month | |||||
| %Chg | -36.00% since 03/08/24 | +2.57% since 08/19/24 | +13.09% since 08/19/24 | -1.64% since 08/19/24 | -2.43% since 08/19/24 |
| Low | 0.1113 on 04/02/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 460.69 on 09/11/24 | 192.25 on 09/13/24 |
| High | 0.3582 on 03/13/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 207.59 on 08/21/24 |
| 3-Month | |||||
| %Chg | -74.24% since 01/08/24 | +9.94% since 06/18/24 | +33.33% since 06/18/24 | +2.73% since 06/18/24 | -10.10% since 06/18/24 |
| Low | 0.1113 on 04/02/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 192.25 on 09/13/24 |
| High | 0.8122 on 01/09/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| 6-Month | |||||
| %Chg | -35.64% since 10/04/23 | +23.80% since 03/19/24 | +14.70% since 03/19/24 | +15.62% since 03/19/24 | -8.04% since 03/19/24 |
| Low | 0.1113 on 04/02/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.8855 on 11/09/23 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 238.00 on 07/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,423 | 178,589,936 | 104,514,608 | 122,358,416 | 28,768,510 |
| Shares Outstanding, K | 52,981 | 536,435 | 1,245,853 | 258,053 | 145,597 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -14,730,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 2,464,900,000 |
| Last Quarter Net Income | -3,090,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 583,600,000 |
| 60-Month Beta | 0.51 | 0.61 | 0.18 | 0.40 | -0.06 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.06 on 02/14/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 5.28 on 08/01/24 |
| Latest Earnings Date | 07/04/24 | 10/29/24 | 11/05/24 | 11/04/24 | 08/01/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 17.89 | 17.67 | 0.00 | 12.19 |